Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid...
Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
/Insulet%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Insulet has outperformed the Dow recently, and analysts remain strongly optimistic about the stock’s prospects.
This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.41%. Stocks today recovered...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.41%. Stocks today are...